HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.

Abstract
Pulmonary artery smooth muscle cell (PA-SMC) proliferation and inflammation are key components of pulmonary arterial hypertension (PAH). Interleukin (IL)-1β binds to IL-1 receptor (R)1, thereby recruiting the molecular adaptor myeloid differentiation primary response protein 88 (MyD88) (involved in IL-1R1 and Toll-like receptor signal transduction) and inducing IL-1, IL-6 and tumour necrosis factor-α synthesis through nuclear factor-κB activation.We investigated the IL-1R1/MyD88 pathway in the pathogenesis of pulmonary hypertension.Marked IL-1R1 and MyD88 expression with predominant PA-SMC immunostaining was found in lungs from patients with idiopathic PAH, mice with hypoxia-induced pulmonary hypertension and SM22-5-HTT(+) mice. Elevations in lung IL-1β, IL-1R1, MyD88 and IL-6 preceded pulmonary hypertension in hypoxic mice. IL-1R1(-/-), MyD88(-/-) and control mice given the IL-1R1 antagonist anakinra were protected similarly against hypoxic pulmonary hypertension and perivascular macrophage recruitment. Anakinra reversed pulmonary hypertension partially in SM22-5-HTT(+) mice and markedly in monocrotaline-treated rats. IL-1β-mediated stimulation of mouse PA-SMC growth was abolished by anakinra and absent in IL-1R1(-/-) and MyD88(-/-) mice. Gene deletion confined to the myeloid lineage (M.lys-Cre MyD88(fl/fl) mice) decreased pulmonary hypertension severity versus controls, suggesting IL-1β-mediated effects on PA-SMCs and macrophages. The growth-promoting effect of media conditioned by M1 or M2 macrophages from M.lys-Cre MyD88(fl/fl) mice was attenuated.Pulmonary vessel remodelling and inflammation during pulmonary hypertension require IL-1R1/MyD88 signalling. Targeting the IL-1β/IL-1R1 pathway may hold promise for treating human PAH.
AuthorsAurélien Parpaleix, Valérie Amsellem, Amal Houssaini, Shariq Abid, Marielle Breau, Elisabeth Marcos, Daigo Sawaki, Marion Delcroix, Rozenn Quarck, Aurélie Maillard, Isabelle Couillin, Bernhard Ryffel, Serge Adnot
JournalThe European respiratory journal (Eur Respir J) Vol. 48 Issue 2 Pg. 470-83 (08 2016) ISSN: 1399-3003 [Electronic] England
PMID27418552 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright ©ERS 2016.
Chemical References
  • Culture Media, Conditioned
  • IL1R1 protein, human
  • IL1R1 protein, mouse
  • Interleukin 1 Receptor Antagonist Protein
  • MYD88 protein, human
  • Myd88 protein, mouse
  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • Receptors, Interleukin-1 Type I
  • Monocrotaline
Topics
  • Animals
  • Cell Differentiation
  • Cell Proliferation
  • Culture Media, Conditioned (chemistry)
  • Gene Deletion
  • Humans
  • Hypertension, Pulmonary (metabolism)
  • Inflammation
  • Interleukin 1 Receptor Antagonist Protein (chemistry)
  • Macrophages (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Monocrotaline (chemistry)
  • Myeloid Differentiation Factor 88 (metabolism)
  • Myocytes, Smooth Muscle (metabolism)
  • NF-kappa B (metabolism)
  • Rats
  • Rats, Wistar
  • Receptors, Interleukin-1 Type I (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: